TMEM16F Regulates Baseline Phosphatidylserine Exposure and Cell Viability in Human Embryonic Kidney Cells

Abstract

Insights

Transmembrane protein 16F (TMEM16F) regulates human embryonic kidney cell viability and proliferation. Its knockdown reduces cell growth and viability, impacting phospholipid scramblase and AKT signaling pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • TMEM16F is a Ca2+-activated transmembrane protein family member.
  • It exhibits phospholipid scramblase and Ca2+-activated electrolyte channel activity.
  • TMEM16F is implicated in cell cycle control and apoptotic signaling.

Purpose of the Study:

  • To investigate the role of TMEM16F in cell proliferation and viability.
  • To assess TMEM16F's impact on Human Embryonic Kidney (HEK293) cells.

Main Methods:

  • Generated inducible TMEM16F knockdown in HEK293 cells.
  • Assessed apoptosis and proliferation markers using flow cytometry and Western blotting.
  • Utilized MTT uptake assay to evaluate cell viability.

Main Results:

  • TMEM16F knockdown attenuated HEK293 cell growth and viability.
  • Phosphatidylserine exposure increased, while viable cell fraction decreased.
  • Observed simultaneous activation of pro- and anti-apoptotic pathways (Caspase 3, Cyclin D1) and AKT signaling.

Conclusions:

  • TMEM16F influences Human Embryonic Kidney cell viability.
  • Its function as a phospholipid scramblase and AKT pathway activation are key mechanisms.

Related Concept Videos